medigraphic.com
SPANISH

Ginecología y Obstetricia de México

Federación Mexicana de Ginecología y Obstetricia, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2022, Number 04

<< Back

Ginecol Obstet Mex 2022; 90 (04)

Dedifferentiated vulvar liposarcoma with homologous differentiation to pleomorphic liposarcoma: case report

Crespín MA, Alas-Pineda C, Gaitán-Zambrano K, Enamorado-Leiva O, Vasquez-Bonilla WO, Bejarano-Cáceres S
Full text How to cite this article

Language: Spanish
References: 15
Page: 378-383
PDF size: 366.84 Kb.


Key words:

Liposarcoma, Soft tissue neoplasms, Hernia, inguinal, Biopsy, Dedifferentiated liposarcoma, Pleomorphic liposarcoma.

ABSTRACT

Background: Liposarcomas are a type of soft tissue tumor. The dedifferentiated subtype is one of the most common variants along with well-differentiated liposarcoma.
Clinical case: A 68-year-old female patient presented for consultation due to the appearance of a mass in the vaginal area which was clinically diagnosed as a direct inguinal hernia. Surgical resection of the mass was performed. The histopathological report was myofibrolipoma, without atypia and with borders free of neoplasia. Three years later, the patient returned to the office for recurrence of the mass and refused a new biopsy. Subsequently, in 2020, the patient accepted the resection of the mass; the histopathologic report was: dedifferentiated liposarcoma with lipoblastic differentiation homologous to pleomorphic liposarcoma.
Conclusion: Histopathological studies are necessary for confirmation of the diagnosis and surgical resection is the treatment of choice.


REFERENCES

  1. Kwak JH, Shin SM, Kim JW, Lee NW. Unusual bilateral vulvar liposarcoma. Obstet Gynecol Sci 2014; 57 (6): 549-52. https://doi.org/10.5468/ogs.2014.57.6.549

  2. Mariño-Enríquez A, Hornick JL, Dal Cin P, Cibas ES, et al. Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration. Cancer Cytopathology 2014; 122: 128-37. https://doi.org/10.1002/cncy.21362

  3. Xie C, Shen Y. Primary dedifferentiated Liposarcoma of vagina: a first case report. Diagn Pathol 2021; 16 (1): 3. https://doi.org/10.1186/s13000-020-01062-3

  4. Yang L, Chen S, Luo P, Yan W, et al. Liposarcoma: Advances in Cellular and Molecular Genetics Alterations and Corresponding Clinical Treatment. Journal of Cancer 2020; 11 (1): 100-7. https://doi.org/10.7150/jca.36380

  5. Crago AM, Dickson MA. Liposarcoma: multimodality management and future targeted therapies. Surg Oncol Clin N Am 2016; 25 (4): 761-73. https://doi.org/10.1016/j. soc.2016.05.007

  6. Ashraf Ganjooie T. Case report of vulvar liposarcoma. J Obstet Gynaecol Res 2004; 30 (2): 80-83. https://doi. org/10.1111/j.1447-0756.2003.00162.x

  7. Chokoeva A, Tchernev G, Cardoso J, Peterson J, et al. Vulvar sarcomas: Short guideline for histopathological recognition and clinical management. Part 2. Int J of Inmunopathol Pharmacol 2015; 28 (2): 178-86. https://doi. org/10.1177%2F0394632015575977

  8. Redroban L, Montalvo N. Vulvar Myxoid Liposarcoma, an Extreme Rare Diagnosis: A Case Report and Review of Literature. Int J Gynecol Pathol 2019; 38 (1): 17-20. https:// doi.org/10.1097/PGP.0000000000000460

  9. John Lee AT, Thway K, Huang PH, Lewis Jones R. Clinical and Molecular Spectrum of Liposarcoma. J Clinical Oncol 2017; 36: 151-59. https://doi.org/10.1200/JCO.2017.74.9598

  10. Fletcher CDM, Bridge JA, Hogendoom PCW, Mertenes F. WHO Classification of Tumours of Soft Tissue and Bone. 4th ed; 2013.

  11. Peterson JJ, Kransdorf MJ, Bancroft LW, O'Connor MI. Malignant fatty tumors: classification, clinical course, imaging appearance and treatment. Skeletal Radiol 2003; 32: 493-503. https://doi.org/10.1007/s00256-003-0647-8

  12. Mariño-Enríquez A, Fletcher C, Dal Cin P, Hornick JL. Dedifferentiated liposarcoma with ‘‘homologous’’ lipoblastic (pleomorphic liposarcoma-like) differentiation: Clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria. Arm J Surg Patho 2010; 34(8). https://doi.org/10.1097/PAS.0b013e3181e5dc49

  13. Saeed-Chesterman D, Thway K. Homologous lipoblastic differentiation in dedifferentiated liposarcoma. Int J Surg Pathol 2016; 24 (3): 237-9. https://doi. org/10.1177/1066896915621966

  14. Gootee J, Aurit S, Curtin C, Silberstein P. Primary anatomical site, adjuvant therapy, and other prognostic variables for dedifferentiated liposarcoma. J Cancer Res Clin Oncol 2019; 145 (1): 181-92. https://doi.org/10.1007/s00432- 018-2777-3

  15. Nassif NA, Tseng W, Borges C, Chen P, et al. Recent advances in the management of liposarcoma. F100Research 2016; 5: 2907. https://doi.org/10.12688/f1000research.10050.1




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ginecol Obstet Mex. 2022;90